Ken Griffin Io Biotech, Inc. Transaction History
Citadel Advisors LLC
- $483 Billion
- Q2 2024
A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Io Biotech, Inc. stock. As of the latest transaction made, Citadel Advisors LLC holds 86,894 shares of IOBT stock, worth $92,107. This represents 0.0% of its overall portfolio holdings.
Number of Shares
86,894
Previous 58,622
48.23%
Holding current value
$92,107
Previous $101,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding IOBT
# of Institutions
20Shares Held
25.9MCall Options Held
988KPut Options Held
0-
Vivo Capital, LLC Palo Alto, CA6.17MShares$6.54 Million1.07% of portfolio
-
Novo Holdings Hellerup, G74.43MShares$4.7 Million0.37% of portfolio
-
Samsara Bio Capital, LLC Palo Alto, CA3.64MShares$3.86 Million2.19% of portfolio
-
Pfm Health Sciences, LP San Francisco, CA2.34MShares$2.48 Million0.14% of portfolio
-
Marshall Wace, LLP London, X02.11MShares$2.23 Million0.0% of portfolio
About IO Biotech, Inc.
- Ticker IOBT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 28,815,300
- Market Cap $30.5M
- Description
- IO Biotech, Inc., a clinical-stage biopharmaceutical company, develops immune-modulating cancer therapies based on the T-win technology platform. The company's lead product candidate, IO102-IO103, which is designed to target immunosuppressive proteins, such as Indoleamine 2,3-dehydrogenase (IDO), and programmed death-ligand (PD-L1) that is in ph...